Inflammation of BCG Inoculation Site Scar after the First Dose of an Anti-SARS-CoV-2 mRNA Vaccine

Inflammatory reactions in the Bacillus Calmette-Guérin (BCG) inoculation scar site have been previously described, in association with viral infections. The inflammation of the scar in association with other vaccines has been described with the flu vaccine and, more recently, after the second dose of mRNA anti-SARS-CoV-2 vaccines (mRNA-1273 e BNT162b2), in two healthcare workers. We present the case of a 27-year-old female, without a relevant past medical history, including no previous SARS-CoV-2 infection, and with inflammation of the BCG scar eight days after the first dose of the mRNA anti-SARS-CoV-2 vaccine. Pharmacovigilance and the notification of adverse events should be encouraged, as a way of warding off hesitation in this process.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:36

Enthalten in:

Acta medica portuguesa - 36(2023), 7-8 vom: 03. Juli, Seite 511-514

Sprache:

Portugiesisch

Weiterer Titel:

Inflamação na Cicatriz BCG após Primeira Dose de Vacina mRNA Anti-SARS-CoV-2

Beteiligte Personen:

Barros Rodrigues, João [VerfasserIn]
Pacheco, Maria [VerfasserIn]
Antunes, Ivan [VerfasserIn]
Sousa, Ricardo [VerfasserIn]

Links:

Volltext

Themen:

BCG Vaccine
BNT162 Vaccine
COVID-19 Vaccines
Case Reports
Cicatrix
Drug-Related Side Effects and Adverse Reactions
English Abstract
Journal Article
MRNA Vaccines
RNA, Messenger
SARS-CoV-2

Anmerkungen:

Date Completed 12.07.2023

Date Revised 18.07.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.20344/amp.16971

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM346378001